|
For the second year in a row, the BIO-Windhover partnering event is combined with Pharmaceutical Strategic Outlook for an in-depth analysis on the top issues affecting the industry, creating a dynamic three days of networking and discussion. The conference offers a personal and interactive setting with in-depth on-stage interviews, panels, one-on-one partnering meetings and company presentations by carefully selected biotech companies.
Senior level business development and licensing executives from small to large pharmaceutical and biotechnology companies attend BIO-Windhover/PSO to meet their current and potential strategic partners as well as hear from industry stakeholders and key thought leaders who’ll share practical advice and strategies on how to structure successful deals.
| Keynote Address & Fireside Chat with: |
|
|
 |
Angus Russell
Chief Executive Officer
Shire plc (Bio) |
 |
Susan Desmond-Hellmann, MD, MPH
Chancellor, UCSF
Board of Directors,
Procter & Gamble
Former President, Product Development,
Genentech (Bio) |
|
|
| Keynote R&D Panel with: |
|
|
 |
Mikael Dolsten
President, Worldwide Research and Development
Senior Vice President
Pfizer Inc. (Bio) |
 |
Richard Murray, Ph.D.
SVP
Biologics Research & Development
Merck Research Laboratories (Bio) |
 |
Prof. Dr. Andreas Busch
Head of Global Drug Discovery and Member of the Board of Management
Bayer Schering Pharma AG (Bio) |
|
|
| Keynote M&A Panel with: |
|
|
 |
Gary A. Gabrielsen
Vice President of Business Development
Astellas US LLC (Bio) |
 |
Rinko Ghosh
Senior Vice President, Chief Business Officer
Nektar Therapeutics (Bio) |
 |
Milton H. Grannatt, Ph.D.
Vice President & Head, Negotiations, Respiratory
& New Growth Opportunities
Global Business Development & Licensing
Novartis (Bio) |
|
|
|
|
-
Pfizer
-
GlaxoSmithKline
-
Sanofi-Aventis
-
Novartis
-
AstraZeneca
-
Johnson & Johnson
-
Merck
-
Roche
-
Eli Lilly & Company
-
Bristol-Myers Squibb
-
Amgen
-
Abbott Laboratories
-
Boehringer-Ingelheim
-
Bayer
-
Takeda
-
Genentech
-
Astellas
-
Novo Nordisk
-
Eisai
-
Forest Laboratories
-
May 23-25, 2011
Paris, France
-
September 21-23, 2011
New York, NY - USA
-
November 30-Dec. 2, 2011
Boston, MA - USA
The BIO-Windhover/PSO proprietary partnering system enables attendees to meet one-on-one with other key decision-makers and network with their peers for a more personal experience in an intimate setting.
Pre-meeting - attendees can identify, research and set up meetings with prospective partners by utilizing the partnering database - searchable criteria includes:
- Company and delegate profiles as well as licensing opportunities provided by attendees themselves
- More than 22 therapeutic categories including cardiovascular, oncology, CNS and more
- Products or technologies
- Phase of project market type (specialty or general)
- Geographic marketing rights desired
- Molecule type (small molecule, protein, antibody, peptide, or other macromolecule)
- Mode of administration
**PLUS! Each company profile on the BIO-Windhover partnering software is linked with EBI’s Strategic Transactions and IN VIVO articles database. Strategic Transactions delivers the most comprehensive deals and tech transfer data in the industry, including alliances, financings and M&As across biopharmaceuticals, devices and diagnostics. It is the only deals database featuring available, hyperlinked analysis from Elsevier’s expert editorial team, plus available links to Inteleos, Elsevier’s extensive drug pipeline database.
Transactions Weekly now available to everyone.
Receive free weekly updates from EBI's Strategic Transactions database on the most recent dealmaking activities across health care. Sign up today! |
Your conference investment will provide you with access to:
- 28+ successful strategies from pharma CEOs, heads of R&D and business development, and corporate VCs
- Company/delegate profiles of all attendees prior to attending the meeting
- Links to Elsevier’s Strategic Transactions and IN VIVO articles database which links to each profile, including alliances, financings and M&As, clinical development details, successes, and failures of all products available for partnering
- 1:1 pre-scheduled meetings with your targeted partners
- Eye-opening keynote panel with pharma's strategic leaders on how they pick targets and deal models that are likely to succeed
- 32+ lessons learned from the trenches by the most successful biotech CEOs, large pharma business development executives, and R&D leaders
- 25+ deal case studies on R&D strategy, deal-making, biotech investing, M&A, and more
- A customized agenda: Choose from 50+ strategic presentations on how to build your R&D pipeline, both internally and externally
- 11+ networking opportunities with the most senior level executives in the biopharma business
- 40 presentations from the most exciting new companies
- FREE pre-conference workshops
- Plus, you are in close-proximity to several pharmaceutical and biotech companies located in the NY-metro area for meetings
Hear what past attendees have to say about BIO-Windhover/PSO:
"I thought this was great to have together and created the best use of my time. It allowed me to personally meet people on a social and business level." - Randall B. Riggs,
President & CEO,
Advanced Cancer Therapeutics
"The BIO-Windover Partnering Conference provided opportunities to meet new potential partners as well as conveniently remaining in contact with potential partners with programs we are currently in communication about." - Mike McBride, Sr.
Director, Industry Relations,
Upsher-Smith Laboratories Inc.
Register now and search your company’s and other companies’ profiles and products!
For more information, please contact:
Best experienced using Internet Explorer 7+.
Add to Outlook Calendar
STAY CONNECTED
Join our BIO-Windhover/PSO event on
 |
| Important Partnering Deadlines |
| Last Chance for Early Bird-Rate (SAVE $200) |
02/28/2010 |
| Last Chance for Discounted Rooms (rooms may sell out before this date) |
03/08/2011 |
| Partnering Opens (start scheduling meetings) |
03/04/2011 |
| Attendee/Company Profile Due |
03/18/2011 |
Click Here to view full pricing schedule.
Who will you meet?
- • C-Level
- • Business Development
- • Strategic Alliances
- • Licensing
- • Strategic Planning
- • Corporate Development
- • R&D
- • M&A
- • Transactions
- • Decision Support
- • Market Access
- • Global Discovery Alliances
- • Financial and Strategic Planning
- • Healthcare Venture Capital/Analysts
- • Clinical Development
- • Alliance Management
- • Portfolio Management
- • Technology Transfer/Academia
- • Intellectual Property
- • Venture Philanthropy Orgs
- • Equity Research
- • Private Equity
2011 Attending Companies
Benefits of Attending
-
• Meet your potential partner and find out how to approach them
-
• Benchmark your dealmaking against the best and the brightest
-
• Learn the deal values and deal specifics that let you calibrate deal-making metrics
-
• Get key trend analysis on new business models, deal structures and deal failures
-
• Maximize your strategic alliance opportunities by meeting business development leaders who’ll share practical advice and strategies on how to structure successful deals
-
• Walk away with practical, real-life lessons from some of the most experienced dealmakers in the industry on how they evaluate opportunities and risk
About Partnering
Why Use Windhover Conferences Partnering Software?
- • Identify attendees to choose potential partners.
- • Search database of partnering/investing opportunities (including deal history and related articles).
- • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
- • Showcase your company's innovative technology and investment/partnering interests.
More Info >>
Follow us on:
|
|